The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 12, 2012

Filed:

Aug. 23, 2004
Applicants:

Cedric Francois, Louisville, KY (US);

Pascal Deschatelets, Louisville, KY (US);

Paul Olson, Louisville, KY (US);

Alec Machiels, New York, NY (US);

Inventors:

Cedric Francois, Louisville, KY (US);

Pascal Deschatelets, Louisville, KY (US);

Paul Olson, Louisville, KY (US);

Alec Machiels, New York, NY (US);

Assignee:

Potentia Pharmaceuticals, Inc., Crestwood, KY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); C12Q 1/00 (2006.01); G01N 33/53 (2006.01); G01N 33/567 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides a system for enhancing clearance or destruction of undesirable cells or noncellular molecular entities by tagging such cells or noncellular molecular entities with a marker that targets the cells or noncellular molecular entities for phagocytosis (phagocytic marker). The target cells can be, for example, endothelial cells, tumor cells, leukocytes, or virus-infected cells. In certain embodiments of the invention the tagging is accomplished by administering a composition comprising an antibody or ligand linked to the phagcytotic marker, wherein the antibody or ligand binds to a cell type specific marker present on or in the cell surface of a target cell. In preferred embodiments of the invention, the phagocytic marker comprises phosphatidylserine or a group derived from phosphatidylserine, thrombospondin-1, annexin I, or a derivative of any of these.


Find Patent Forward Citations

Loading…